论文部分内容阅读
采用蕲蛇酶注射液治疗急性期脑梗塞患者60例,与同期收治的用脉络宁治疗的急性期脑梗塞患者58例做对照。治疗前两组患者各方面情况相似(P>0.05),具有可比性。结果表明:蕲蛇酶组在临床症状、体征改善上疗效明显优于脉络宁组。
Fifty cases of acute cerebral infarction were treated with Acutobin injection and 58 cases of acute cerebral infarction treated with Mailuoning over the same period. The two groups before treatment were similar in all aspects (P> 0.05), comparable. The results showed that: Acuminase group in the clinical symptoms and signs of improvement was significantly better than Mailuoning group.